Oxidative stress in psychiatric disorders: evidence base and therapeutic implications
Open accessAbstract
Oxidative stress has been implicated in the pathogenesis of diverse disease states, and may be a common pathogenic mechanism underlying many major psychiatric disorders, as the brain has comparatively greater vulnerability to oxidative damage. This review aims to examine the current evidence for the role of oxidative stress in psychiatric disorders, and its academic and clinical implications. A literature search was conducted using the Medline, Pubmed, PsycINFO, CINAHL PLUS, BIOSIS Preview, and Cochrane databases, with a time-frame extending to September 2007. The broadest data for oxidative stress mechanisms have been derived from studies conducted in schizophrenia, where evidence is available from different areas of oxidative research, including oxidative marker assays, psychopharmacology studies, and clinical trials of antioxidants. For bipolar disorder and depression, a solid foundation for oxidative stress hypotheses has been provided by biochemical, genetic, pharmacological, preclinical therapeutic studies and one clinical trial. Oxidative pathophysiology in anxiety disorders is strongly supported by animal models, and also by human biochemical data. Pilot studies have suggested efficacy of N-acetylcysteine in cocaine dependence, while early evidence is accumulating for oxidative mechanisms in autism and attention deficit hyperactivity disorder. In conclusion, multi-dimensional data support the role of oxidative stress in diverse psychiatric disorders. These data not only suggest that oxidative mechanisms may form unifying common pathogenic pathways in psychiatric disorders, but also introduce new targets for the development of therapeutic interventions.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Stress related to psychopathology is associated with physiological and cellular alterations related to telomere length, such as elevated oxidative stress or inflammation.
“This model is consistent with the idea that stress related to psychopathology is associated with physiological and cellular alterations related to telomere length, such as elevated oxidative stress or inflammation.25”
From Telomere Length and Psychopathology: Specificity and Direction of Effects Within the Bucharest Early Intervention Project (2020) · cites this paper as [25]
Oxidative stress in psychiatric disorders could result from overproduction of ROS, impairments in Keap1-Nrf2 signalling, or both, due to psychological stress, physiological impairments, inflammation, and genetic polymorphisms of antioxidant enzymes.
“Oxidative stress in psychiatric disorders could result from the overproduction of ROS, impairments in Keap1-Nrf2 signalling, or both due to causes related to psychological stress, physiological impairments, inflammation, and genetic polymorphisms of antioxidant enzymes that are beyond the scope of this review [126,127].”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [126]
Antioxidants have shown promising therapeutic benefits in the treatment of psychiatric disorders.
“Importantly, antioxidants have shown promising therapeutic benefits in the treatment of psychiatric disorders and are subject to further investigation [126,127,140].”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [126]
Increased oxidative damage occurs quite often in bipolar disorder.
“bipolar disorder (BD) [10–14]”
From Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches (2016) · cites this paper as [13]
NAC, which is a precursor of glutathione, can significantly improve the standard therapy, as a double-blind randomized placebo-controlled clinical study performed by Ng et al. in 2008 demonstrated.
“Coming back to NAC, which is a precursor of glutathione, it has been shown that it can significantly improve the standard therapy, as a double-blind randomized placebo-controlled clinical study performed by Ng et al. in 2008 demonstrated [13].”
From Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches (2016) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Free radicals and antioxidants in normal physiological functions and human disease
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269 · see citing works
Journal of Clinical Psychiatry
(2018) · Journal of Clinical Psychiatry · doi:10.5505/kpd · Cited by 13,703 · see citing works
Oxidants, oxidative stress and the biology of ageing
Finkel, T., & Holbrook, N. J. (2000) · Nature · doi:10.1038/35041687 · Cited by 9,413 · see citing works
Nitric Oxide and Peroxynitrite in Health and Disease
Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390 · see citing works
Oxidative stress: oxidants and antioxidants
Sies, H. (1997) · Experimental Physiology · doi:10.1113/expphysiol.1997.sp004024 · Cited by 4,577 · see citing works
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683 · see citing works
Self-citationOxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614 · see citing works
Vitamin E, antioxidant and nothing more
Traber, M. G., & Atkinson, J. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.024 · Cited by 1,501 · see citing works
Untreated Depression and Hippocampal Volume Loss
Sheline, Y. I., Gado, M. H., & Kraemer, H. C. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.8.1516 · Cited by 1,180 · see citing works
Oxidative stress: the paradox of aerobic life
Davies, K. J. A. (1995) · Biochemical Society Symposia · doi:10.1042/bss0610001 · Cited by 1,150 · see citing works
Prabakaran, S., SWATTON, J. E., Ryan, M. M., Huffaker, S. J., Huang, J.-J., Griffin, J. L., Wayland, M. T., Freeman, T., Dudbridge, F., Lilley, K. S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001511 · Cited by 973 · see citing works
James, S. J., Cutler, P., Melnyk, S., Jernigan, S., Janak, L., Gaylor, D. W., & Neubrander, J. A. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1611 · Cited by 955 · see citing works
The Emerging Role of Glutamate in the Pathophysiology and Treatment of Schizophrenia
GOFF, D. C., & Coyle, J. T. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.9.1367 · Cited by 914 · see citing works
Young, T. K. (1973) · New England Journal of Medicine · doi:10.1056/nejm197307122890231 · Cited by 903 · see citing works
Journal of Affective Disorders
Flint, A. J., & Rifat, S. L. (1996) · Journal of Affective Disorders · doi:10.1016/0165-0327(96)00074-2 · Cited by 864 · see citing works
Oxidative Stress, Antioxidant Defenses, and Damage Removal, Repair, and Replacement Systems
Davies, K. J. A. (2000) · IUBMB Life · doi:10.1080/713803728 · Cited by 774 · see citing works
N-Acetylcysteine—a safe antidote for cysteine/glutathione deficiency
Atkuri, K. R., Mantovani, J. J., Herzenberg, L. A., & Herzenberg, L. A. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.04.005 · Cited by 721 · see citing works
Bilici, M., Efe, H., Köroğlu, M. A., Uydu, H. A., Bekaroğlu, M., & Değer, O. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00199-3 · Cited by 718 · see citing works
Oxidative Stress, Antioxidant Defenses, and Damage Removal, Repair, and Replacement Systems
Davies, K. J. A. (2000) · IUBMB Life · doi:10.1080/15216540051081010 · Cited by 608 · see citing works
James, S. J., Melnyk, S., Jernigan, S., Cleves, M. A., Halsted, C. H., Wong, D. H., Cutler, P., Bock, K., Boris, M., Bradstreet, J., et al. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30366 · Cited by 605 · see citing works
Depletion of Omega-3 Fatty Acid Levels in Red Blood Cell Membranes of Depressive Patients
Peet, M., Murphy, B., Shay, J., & Horrobin, D. F. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00206-0 · Cited by 581 · see citing works
Tansey, M. G., McCoy, M. K., & Frank-Cannon, T. C. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.07.004 · Cited by 580 · see citing works
Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo
Do, K. Q., Trabesinger, A. H., Kirsten‐Krüger, M., Lauer, C. J., Dydak, U., Hell, D., Holsboer, F., Boesiger, P., & Cuénod, M. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00229.x · Cited by 540 · see citing works
The International Journal of Neuropsychopharmacology
Lerer, B., Frazer, A., Stahl, S. M., Farde, L., & Lesch, K. (1998) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145798009018 · Cited by 500 · see citing works
Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice
Hovatta, I., Tennant, R. S., Helton, R., Marr, R. A., Singer, O., Redwine, J. M., Ellison, J. A., Schadt, E. E., Verma, I. M., Lockhart, D. J., et al. (2005) · Nature · doi:10.1038/nature04250 · Cited by 498 · see citing works
Chen, G., Zeng, W., YUAN, P., Huang, L., Jiang, Y., Zhao, Z., & Manji, H. K. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.720879.x · Cited by 489 · see citing works
Sarandol, A., Sarandol, E., Eker, S. S., Erdinc, S., Vatansever, E., & Kirli, S. (2007) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.829 · Cited by 486 · see citing works
THE BRITISH JOURNAL OF NUTRITION
(1948) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1948.tb97074.x · Cited by 480 · see citing works
Khanzode, S. D., Dakhale, G. N., Khanzode, S. S., Saoji, A., & Palasodkar, R. (2003) · Redox Report · doi:10.1179/135100003225003393 · Cited by 458 · see citing works
Chauhan, A., Chauhan, V., Brown, W. T., & Cohen, I. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.04.038 · Cited by 424 · see citing works
Ranjekar, P. K., Hinge, A. S., Hegde, M. V., Ghate, M. R., Kale, A. A., Sitasawad, S. L., Wagh, U. V., Debsikdar, V. B., & Mahadik, S. P. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00220-8 · Cited by 395 · see citing works
Molecular mechanism of α-tocopherol action
Azzi, A. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.013 · Cited by 380 · see citing works
Non-Antioxidant Activities of Vitamin E
Zingg, J.-M. A., & Azzi, A. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043365332 · Cited by 377 · see citing works
Prabakaran, S., SWATTON, J. E., Ryan, M. M., Huffaker, S. J., Huang, J. T.-J., Griffin, J. L., Wayland, M. T., Freeman, T., Dudbridge, F., Lilley, K. S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001532 · Cited by 375 · see citing works
Glutathione Precursor, N-Acetyl-Cysteine, Improves Mismatch Negativity in Schizophrenia Patients
Lavoie, S., Murray, M. M., Deppen, P., Knyazeva, M. G., Berk, M., Boulat, O., Bovet, P., Bush, A. I., Conus, P., Copolov, D., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301624 · Cited by 371 · see citing works
Self-citationAntioxidant enzyme activities and oxidative stress in affective disorders
Erkan Ozcan, M., Gulec, M., Ozerol, E., Polat, R., & Akyol, O. (2004) · International Clinical Psychopharmacology · doi:10.1097/00004850-200403000-00006 · Cited by 368 · see citing works
Hayley, S., Poulter, M. O., Merali, Z., & Anisman, H. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.051 · Cited by 324 · see citing works
Herken, H., Gurel, A., Selek, S., Armutcu, F., Ozen, M. E., Bulut, M., Kap, O., Yumru, M., Savas, H. A., & Akyol, O. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2006.10.005 · Cited by 322 · see citing works
Altered glutathione redox state in schizophrenia.
Yao, J. K., Leonard, S., & Reddy, R. (2006) · Disease Markers · doi:10.1155/2006/248387 · Cited by 321 · see citing works
Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder
Kuloglu, M., Ustundag, B., Atmaca, M., Canatan, H., Tezcan, A. E., & Cinkilinc, N. (2002) · Cell Biochemistry and Function · doi:10.1002/cbf.940 · Cited by 321 · see citing works
Machado‐Vieira, R., Andreazza, A. C., Viale, C. I., Zanatto, V. C., Ceresér, V. H., Vargas, R. D. S., Kapczinski, F. P., Portela, L. V., Souza, D. O., Salvador, M. M., et al. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.05.016 · Cited by 314 · see citing works
Impaired glutathione synthesis in schizophrenia: Convergent genetic and functional evidence
Gysin, R., Kraftsik, R., Sandell, J., Bovet, P., Chappuis, C., Conus, P., Deppen, P., Preisig, M., Ruiz, V., Steullet, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706778104 · Cited by 309 · see citing works
Serum S100B and antioxidant enzymes in bipolar patients
Andreazza, A. C., Cassini, C., Rosa, A. R., Leite, M. C., de Almeida, L. M. V., Nardin, P., da Cunha, A. B., Ceresér, K. M. M., Santin, A. M. P., Gottfried, C., et al. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.07.013 · Cited by 307 · see citing works
Increased Serum Levels of 8-Hydroxy-2′-Deoxyguanosine in Clinical Depression
Forlenza, M. J., & Miller, G. E. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000195780.37277.2a · Cited by 307 · see citing works
Khan, M. M. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00334-6 · Cited by 300 · see citing works
Arvindakshan, M. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00284-0 · Cited by 281 · see citing works
Akyol, Ö., Herken, H., Uz, E., Fadıllıoğlu, E., Ünal, S., Söğüt, S., Özyurt, H., & SAVAS, H. A. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00220-8 · Cited by 278 · see citing works
Bouayed, J., Rammal, H., Dıcko, A., Younos, C., & Soulimani, R. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.06.028 · Cited by 278 · see citing works
Söğüt, S., Zoroğlu, S. S., Özyurt, H., Yilmaz, H. R., Özuğurlu, F., Sivaslı, E., Yetkin, Ö., Yanık, M., Tutkun, H., SAVAS, H. A., et al. (2003) · Clinica Chimica Acta · doi:10.1016/s0009-8981(03)00119-0 · Cited by 275 · see citing works
Lower serum vitamin E concentrations in major depression
Maes, M. H. J., Vos, N. D., Pioli, R., Demedts, P., Wauters, A., Neels, H. M., & Christophe, A. B. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00121-4 · Cited by 274 · see citing works
Zhang, X., Tan, Y. L., Cao, L. Y., Wu, G. Y., Xu, Q., Shen, Y., & Zhou, D. F. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.10.011 · Cited by 262 · see citing works
Oxidative Stress Responses in Older Men during Endurance Training and Detraining
Fatouros, I. G., Jamurtas, A. Z., Villiotou, V., POULIOPOULOU, S., Foteinakis, P. F., Taxildaris, K., & Deliconstantinos, G. (2004) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000147632.17450.ff · Cited by 246 · see citing works
Binder, M. D., Hirokawa, N., & Windhorst, U. (2008) · Springer eBooks · doi:10.1007/978-3-540-29678-2_3942 · Cited by 245 · see citing works
Frey, B. N., Valvassori, S. S., Réus, G. Z., Martins, M. R., Petronilho, F. C., Bardini, K., Dal‐Pizzol, F., Kapczinski, F. P., & Quevedo, J. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0637 · Cited by 238 · see citing works
Herken, H., Uz, E., Özyurt, H., Söğüt, S., Vırıt, O., & Akyol, Ö. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000789 · Cited by 238 · see citing works
Increased excretion of a lipid peroxidation biomarker in autism
Ming, X., Stein, T. P., Brimacombe, M., Johnson, W. G., Lambert, G. H., & Wagner, G. C. (2005) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.06.002 · Cited by 236 · see citing works
Zoroğlu, S. S., Armutçu, F., Özen, Ş., Gürel, A., Sivaslı, E., Yetkin, O., & Meram, İ. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0456-7 · Cited by 235 · see citing works
Eren, İ., Nazıroğlu, M., & Demirdaş, A. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9289-x · Cited by 234 · see citing works
Schizophrenia and Oxidative Stress: Glutamate Cysteine Ligase Modifier as a Susceptibility Gene
Tosic, M., Ott, J., Barral, S., Bovet, P., Deppen, P., Gheorghita, F., Matthey, M.-L., Parnas, J., Preisig, M., Saraga, M., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/507566 · Cited by 234 · see citing works
Arvindakshan, M., Sitasawad, S. L., Debsikdar, V. B., Ghate, M. R., Evans, D. R., Horrobin, D. F., Bennett, C. N., Ranjekar, P. K., & Mahadik, S. P. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01443-9 · Cited by 232 · see citing works
Zhou, W., & Kalivas, P. W. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.06.008 · Cited by 225 · see citing works
Parikh, V., Khan, M. M., & Mahadik, S. P. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00048-1 · Cited by 224 · see citing works
Shao, L., Young, L. T., & Wang, J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.052 · Cited by 218 · see citing works
Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats
Andreassen, O. A., & Jørgensen, H. A. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00064-7 · Cited by 211 · see citing works
Is Cocaine Desire Reduced by N -Acetylcysteine?
LaRowe, S. D., Myrick, H., Hedden, S. L., Mardikian, P. N., Saladin, M. E., McRae‐Clark, A. L., Brady, K. T., Kalivas, P. W., & Malcolm, R. J. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.7.1115 · Cited by 210 · see citing works
Khawaja, X. Z., Xu, J., Liang, J., & Barrett, J. E. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.10869 · Cited by 208 · see citing works
Investigation of antioxidant enzymes in children with autistic disorder
Yorbık, Ö., Sayal, A., Akay, C., Akbiyik, D. I., & Söhmen, T. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2002.0439 · Cited by 207 · see citing works
Landgraf, R., Kessler, M. S., Bunck, M., Murgatroyd, C., Spengler, D., Zimbelmann, M., Nußbaumer, M., Czibere, L., Turck, C. W., Singewald, N., et al. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.07.003 · Cited by 199 · see citing works
Reduced plasma antioxidants in first-episode patients with schizophrenia
Reddy, R. D. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00407-3 · Cited by 194 · see citing works
The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia
Benes, F. M., Matzilevich, D., Burke, R. E., & Walsh, J. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001758 · Cited by 183 · see citing works
Safety and Tolerability of N‐Acetylcysteine in Cocaine‐Dependent Individuals
LaRowe, S. D., Mardikian, P. N., Malcolm, R. J., Myrick, H., Kalivas, P. W., McFarland, K., Saladin, M. E., McRae‐Clark, A. L., & Brady, K. T. (2006) · American Journal on Addictions · doi:10.1080/10550490500419169 · Cited by 181 · see citing works
Kuloğlu, M., Atmaca, M., Tezcan, E., Geçici, Ö., Tunckol, H., & Üstündağ, B. (2002) · Neuropsychobiology · doi:10.1159/000063573 · Cited by 178 · see citing works
Vitamin C and Vitamin E for Alzheimer's Disease
Boothby, L. A., & Doering, P. L. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e495 · Cited by 175 · see citing works
The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode
Selek, S., Savas, H. A., Gergerlioglu, H. S., Bulbul, F., Uz, E., & Yumru, M. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.08.006 · Cited by 172 · see citing works
Mehta, J. L., Rasouli, N., Sinha, A. K., & Molavi, B. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.12.008 · Cited by 169 · see citing works
Abdalla, D. S. P., Monteiro, H., Oliveira, J., & Bechara, E. J. H. (1986) · Clinical Chemistry · doi:10.1093/clinchem/32.5.805 · Cited by 168 · see citing works
Dietrich, J.-B., Mangeol, A., Revel, M.-O., Burgun, C., Aunis, D., & Zwiller, J. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.01.018 · Cited by 168 · cited 1× · see citing works
“, 2005), cocaine (Dietrich et al., 2005) and amphetamines (Frey et al.”
BackgroundAnxiolytic properties of green tea polyphenol (−)-epigallocatechin gallate (EGCG)
Vignes, M., Maurice, T., Lanté, F., Nedjar, M., Thethi, K., Guiramand, J., & Récasens, M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.06.062 · Cited by 167 · see citing works
Evans, D. R., Parikh, V., Khan, M. M., Coussons, C., Buckley, P. F., & Mahadik, S. P. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.08.010 · Cited by 164 · see citing works
Elevated Plasma Lipid Peroxides at the Onset of Nonaffective Psychosis
Mahadik, S. P., Mukherjee, S., Scheffer, R. E., Correnti, E. E., & Mahadik, J. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00282-5 · Cited by 163 · see citing works
Reduced status of plasma total antioxidant capacity in schizophrenia
Yao, J. K., Reddy, R. D., McElhinny, L. G., & van Kammen, D. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00030-9 · Cited by 161 · see citing works
Venlafaxine Modulates Depression-Induced Oxidative Stress in Brain and Medulla of Rat
Eren, İ., Nazıroğlu, M., Demirdaş, A., Çelik, Ö., Uğuz, A. C., Altunbaşak, A., Özmen, İ., & Uz, E. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9258-9 · Cited by 161 · see citing works
Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate
Cui, J., Shao, L., Young, L. T., & Wang, J.-F. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.010 · Cited by 160 · see citing works
Pillai, A., Parikh, V., Terry, A. V., & Mahadik, S. P. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.01.011 · Cited by 153 · see citing works
N‐Acetyl Cysteine‐Induced Blockade of Cocaine‐Induced Reinstatement
Baker, D. L., McFarland, K., LAKE, R. W., Shen, H., Toda, S., & Kalivas, P. W. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.023 · Cited by 148 · see citing works
Oxidative Stress Produced by Marijuana Smoke: An Adverse Effect Enhanced by Cannabinoids
Sarafian, T. A., Marques-Magallanes, J. A., Shau, H., Tashkin, D. P., & Roth, M. D. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.20.6.3424 · Cited by 147 · see citing works
Hippocampal Volumes in Schizophrenic Twins
van Erp, T. G. M., Saleh, P. A., HUTTUNEN, M. O., Lönnqvist, J. K., Kaprio, J. A., Salonen, O. L. M., Valanne, L. K., Poutanen, V.-P., Standertskjöld-Nordenstam, C.-G., & Cannon, T. D. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.4.346 · Cited by 147 · see citing works
Increased Nitric Oxide Radicals in Postmortem Brain From Patients With Schizophrenia
YAO, J. K., Leonard, S. S., & Reddy, R. D. (2004) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007142 · Cited by 146 · see citing works
SAVAS, H. A., Gergerlioğlu, H. S., Armutçu, F., Herken, H., Yılmaz, H. R., Koçoğlu, E., Selek, S., Tutkun, H., Zoroğlu, S. S., & Akyol, Ö. (2006) · The World Journal of Biological Psychiatry · doi:10.1080/15622970510029993 · Cited by 143 · see citing works
Selley, M. L. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(03)00135-6 · Cited by 139 · see citing works
Fukami, G., Hashimoto, K., Koike, K., Okamura, N., Shimizu, E., & Iyo, M. (2004) · Brain Research · doi:10.1016/j.brainres.2004.04.072 · Cited by 138 · see citing works
Antioxidant Enzyme and Malondialdehyde Levels in Patients with Panic Disorder
Kuloğlu, M., Atmaca, M., Tezcan, E., Üstündağ, B., & Bulut, S. (2002) · Neuropsychobiology · doi:10.1159/000067810 · Cited by 137 · see citing works
Biomarkers for Oxidative Stress: Clinical Application in Pediatric Medicine
Tsukahara, H. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707779941177 · Cited by 135 · see citing works
Abnormal age-related changes of plasma antioxidant proteins in schizophrenia
Yao, J. K., Reddy, R. D., & van Kammen, D. P. (2000) · Psychiatry Research · doi:10.1016/s0165-1781(00)00230-4 · Cited by 133 · see citing works
Altuntaş, İ., Aksoy, H., Coşkun, İ., Çayköylü, A., & Akçay, F. (2000) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2000.201 · Cited by 131 · see citing works
Dakhale, G. N., Khanzode, S. D., Khanzode, S. S., & Saoji, A. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0117-1 · Cited by 131 · see citing works
Altered Vascular Phenotype in Autism
Yao, Y., Walsh, W. J., McGinnis, W. R., & Praticò, D. (2006) · Archives of Neurology · doi:10.1001/archneur.63.8.1161 · Cited by 131 · see citing works
DEOLIVEIRA, M., SILVESTRIN, R., MELLOESOUZA, T., & MOREIRA, J. (2007) · NeuroToxicology · doi:10.1016/j.neuro.2007.07.008 · Cited by 130 · see citing works
Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide
Wei, Z., Bai, O., Richardson, J. S., Mousseau, D. D., & Li, X. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10668 · Cited by 129 · see citing works
The relationship between potency of oxidative stress and severity of depression
Yanık, M., Erel, Ö., & Katı, M. (2004) · Acta Neuropsychiatrica · doi:10.1111/j.0924-2708.2004.00090.x · Cited by 125 · see citing works
Binder, M. D., Hirokawa, N., & Windhorst, U. (2008) · Springer eBooks · doi:10.1007/978-3-540-29678-2_641 · Cited by 125 · see citing works
Clinical pharmacology and therapeutic use of antioxidant vitamins
Rodrigo, R., Guichard, C., & Charles, R. (2007) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2006.00466.x · Cited by 124 · see citing works
Scorza, F., Cysneiros, R., Cavalheiro, E., Arida, R., & de Albuquerque, M. (2007) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.02.001 · Cited by 122 · see citing works
Desrumaux, C., Risold, P.-Y., Schroeder, H., Deckert, V., Masson, D., Athias, A., Laplanche, H., Le Guern, N., Blache, D., Jiang, X.-C., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2400fje · Cited by 122 · see citing works
Reduced level of plasma antioxidant uric acid in schizophrenia
Yao, J. K., Reddy, R. D., & van Kammen, D. P. (1998) · Psychiatry Research · doi:10.1016/s0165-1781(98)00051-1 · Cited by 121 · see citing works
Increased oxidative stress and DNA damage in bipolar disorder: A twin-case report
Frey, B. N., Andreazza, A. C., Kunz, M., Gomes, F. A., Quevedo, J., Salvador, M., Gonçalves, C. A., & Kapczinski, F. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.06.011 · Cited by 120 · see citing works
Treatment of ADHD with French maritime pine bark extract, Pycnogenol®
Trebatická, J., Kopasová, S., Hradečná, Z., Činovský, K., Škodáček, I., Šuba, J., Muchová, J., Žitňanová, I., Waczulı́ková, I., Rohdewald, P. J., et al. (2006) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-006-0538-3 · Cited by 119 · see citing works
Oxidative Damage and Schizophrenia: The Potential Benefit by Atypical Antipsychotics
Dakhale, G. N., Khanzode, S. D., Khanzode, S. S., Saoji, A., Khobragade, L., & Turankar, A. V. (2004) · Neuropsychobiology · doi:10.1159/000077368 · Cited by 118 · see citing works
Vitamin E Treatment for Tardive Dyskinesia
Adler, L. A. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.9.836 · Cited by 118 · see citing works
Othmen, L. B., Mechri, A., Fendri, C., Bost, M., Chazot, G., Gaha, L., & Kerkeni, A. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.003 · Cited by 117 · see citing works
Cytoprotection by lithium and valproate varies between cell types and cellular stresses
Lai, J. S., Zhao, C., Warsh, J. J., & Li, P. P. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.03.076 · Cited by 116 · see citing works
Gama, C. S., Salvador, M. M., Andreazza, A. C., Kapczinski, F. P., & Belmonte-de-Abreu, P. S. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.11.009 · Cited by 116 · see citing works
Oxidative Stress During Treatment With First- and Second-Generation Antipsychotics
Kropp, S., Kern, V., Lange, K., Degner, D., Hajak, G., Kornhuber, J., Rüther, E., Emrich, H. M., Schneider, U., & Bleich, S. (2005) · Journal of Neuropsychiatry · doi:10.1176/jnp.17.2.227 · Cited by 116 · see citing works
Bouayed, J., Rammal, H., Younos, C., & Soulimani, R. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.02.055 · Cited by 114 · see citing works
Evidence for Oxidative DNA Damage in the Hippocampus of Elderly Patients With Chronic Schizophrenia
Nishioka, N., & Arnold, S. E. (2004) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200403000-00008 · Cited by 114 · see citing works
Mitochondrial Dysfunction as the Molecular Basis of Bipolar Disorder
Kato, T. (2007) · CNS Drugs · doi:10.2165/00023210-200721010-00001 · Cited by 113 · see citing works
Penugonda, S., Mare, S., Goldstein, G. A., Banks, W. A., & Nuran Ercal, A. (2005) · Brain Research · doi:10.1016/j.brainres.2005.07.032 · Cited by 113 · see citing works
Contribution of Cystine–Glutamate Antiporters to the Psychotomimetic Effects of Phencyclidine
Baker, D. L., Madayag, A., Kristiansen, L. V., Meador‐Woodruff, J. H., Haroutunian, V. H., & Raju, I. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301532 · Cited by 112 · see citing works
Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment
Gergerlioğlu, H. S., SAVAS, H. A., Bülbül, F., Selek, S., Uz, E., & Yumru, M. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.12.020 · Cited by 111 · see citing works
Kovacic, P., & Cooksy, A. L. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.07.021 · Cited by 110 · see citing works
Frey, B. N., Martins, M. R., Petronilho, F. C., Dal‐Pizzol, F., Quevedo, J., & Kapczinski, F. P. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00318.x · Cited by 109 · see citing works
Impairment of several immune functions in anxious women
Arranz, L., Guayerbas, N., & la Fuente, M. D. (2006) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2006.07.030 · Cited by 107 · see citing works
Wang, J., Azzam, J. E., & Young, L. T. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00655-3 · Cited by 107 · see citing works
Low plasma vitamin E levels in major depression: diet or disease?
Owen, A. J., Batterham, M. J., Probst, Y., Grenyer, B. F. S., & Tapsell, L. C. (2004) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602072 · Cited by 105 · see citing works
A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
Lohr, J. B., & Caligiuri, M. P. (1996) · PubMed · Cited by 105 · see citing works
Hansen, N. C. G., Skriver, A., Brorson-Riis, L., Balsløv, S., Evald, T., Maltbæk, N., Gunnersen, G., Garsdal, P., Sander, P., Pedersen, J., et al. (1994) · Respiratory Medicine · doi:10.1016/s0954-6111(05)80337-3 · Cited by 104 · see citing works
Sivrioglu, E. Y., Kirli, S., Sipahioglu, D., Gursoy, B., & Sarandöl, E. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.07.004 · Cited by 102 · see citing works
Chovanová, Z., Muchová, J., Sivoňová, M. K., Dvořáková, M., Žitňanová, I., Waczulı́ková, I., Trebatická, J., Škodáček, I., & Ďuračková, Z. (2006) · Free Radical Research · doi:10.1080/10715760600824902 · Cited by 101 · see citing works
Association between Ala–9Val polymorphism of Mn-SOD gene and schizophrenia
Akyol, Ö., Yanık, M., Elyas, H., Namlı, M. N., Canatan, H., Akın, H., Yüce, H., Yilmaz, H. R., Tutkun, H., Söğüt, S., et al. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.10.014 · Cited by 99 · see citing works
Nitrite content and antioxidant enzyme levels in the blood of schizophrenia patients
Srivastava, N., Barthwal, M. K., Dalal, P., Agarwal, A. K., Nag, D., Srimal, R. C., Seth, P. K., & Dikshit, M. (2001) · Psychopharmacology · doi:10.1007/s002130100860 · Cited by 99 · see citing works
Frey, B. N., Valvassori, S. S., Réus, G. Z., Martins, M. R., Petronilho, F. C., Bardini, K., Dal‐Pizzol, F., Kapczinski, F. P., & Quevedo, J. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9070-6 · Cited by 98 · see citing works
N-Acetyl Cysteine in the Treatment of Grooming Disorders
Odlaug, B. L., & Grant, J. E. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000264976.86990.00 · Cited by 94 · see citing works
McQuillin, A., Bass, N. J., Kalsi, G., Lawrence, J., Puri, V., Choudhury, K., Detera‐Wadleigh, S. D., Curtis, D., & Gurling, H. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001759 · Cited by 93 · see citing works
A mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress
Marchbanks, R. M., Ryan, M., Day, I. N. M., Owen, M., McGuffin, P., & Whatley, S. A. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00011-2 · Cited by 93 · see citing works
Wang, H., Xu, H., Dyck, L. E., & Li, X. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20570 · Cited by 93 · see citing works
Sarandöl, A., Kırlı, S., Akkaya, C., Altın, A., Demirci, M., & Sarandöl, E. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.03.008 · Cited by 92 · see citing works
Redox Control of Apoptosis: An Update
Filomeni, G., & Ciriolo, M. R. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.2187 · Cited by 92 · see citing works
Zhang, X. Y., Zhou, D. F., Zhang, P. Y., Wu, G. Y., Su, J. M., & Cao, L. Y. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1107 · Cited by 90 · see citing works
Erşan, S., Bakır, S., Erşan, E. E., & Doğan, O. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.03.034 · Cited by 90 · see citing works
Cu, Zn- and Mn-superoxide dismutase levels in brains of patients with schizophrenic psychosis
Michel, T. M., Thome, J., Martin, D., Keinosuke, N. A. R. A., Zwerina, S., Tatschner, T., Weijers, H. ‐., & Koutsilieri, E. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0160-9 · Cited by 89 · see citing works
Magnetic Resonance Imaging of the Thalamus and Adhesio Interthalamica in Twins With Schizophrenia
Ettinger, U., Picchioni, M., Landau, S., Matsumoto, K., van Haren, N. E. M., Marshall, N., Hall, M., Schulze, K., Toulopoulou, T., Davies, N., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.4.401 · Cited by 85 · see citing works
Shao, L., Sun, X., Xu, L., Young, L. T., & Wang, J. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.07.007 · Cited by 85 · see citing works
Dvořáková, M., Sivoňová, M. K., Trebatická, J., Škodáček, I., Waczulı́ková, I., Muchová, J., & Ďuračková, Z. (2006) · Redox Report · doi:10.1179/135100006x116664 · Cited by 84 · see citing works
Oxidative stress in blood platelets from schizophrenic patients
Dietrich‐Muszalska, A., Olas, B., & Rabe‐Jabłońska, J. (2005) · Platelets · doi:10.1080/09537100500128872 · Cited by 84 · see citing works
Long-term treatment effects of vitamin E for tardive dyskinesia
Adler, L. A., Edson, R., Lavori, P. W., Peselow, E. D., Duncan, E., Rosenthal, M., & Rotrosen, J. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00027-9 · Cited by 83 · see citing works
Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure
Frey, B. N., Valvassori, S. S., Gomes, K. M., Martins, M. R., Dal‐Pizzol, F., Kapczinski, F. P., & Quevedo, J. (2006) · Brain Research · doi:10.1016/j.brainres.2006.04.076 · Cited by 82 · see citing works
Pall, M. L., & Satterlee, J. D. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05836.x · Cited by 81 · see citing works
Harvey, B. H., Joubert, C., du Preez, J. L., & Berk, M. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9466-y · Cited by 81 · see citing works
Self-citationIs the Arginine-Nitric Oxide Pathway Involved in the Pathogenesis of Schizophrenia?
Yanık, M., Vural, H., Koçyiğit, A., Tutkun, H., Zoroğlu, S. S., Herken, H., SAVAS, H. A., Köylü, A., & Akyol, Ö. (2003) · Neuropsychobiology · doi:10.1159/000070010 · Cited by 81 · see citing works
Srivastava, N., Barthwal, M. K., Dalal, P., Agarwal, A., Nag, D., Seth, P. K., Srimal, R. C., & Dikshit, M. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00421-9 · Cited by 80 · see citing works
Do, K. Q., Lauer, C. J., Schreiber, W., Zollinger, M., Gutteck‐Amsler, U., Cuénod, M., & Holsboer, F. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65062652.x · Cited by 79 · see citing works
Ramírez‐Bermúdez, J. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00070-7 · Cited by 77 · see citing works
Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment
Atmaca, M., Tezcan, E., Kuloglu, M., Ustundag, B., & Tunckol, H. (2004) · European Archives of Psychiatry and Clinical Neurosciences · doi:10.1007/s00406-004-0484-3 · Cited by 75 · see citing works
The role of the arginine-nitric oxide pathway in the pathogenesis of bipolar affective disorder
Yanık, M., Vural, H., Tutkun, H., Zoroğlu, S. S., SAVAS, H. A., Herken, H., Ko�yigit, A., Keles, H., & Akyol, �. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0453-x · Cited by 75 · see citing works
The World Journal of Biological Psychiatry
Kasper, S. F. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970903416878 · Cited by 74 · see citing works
Free radicals in patients with post-traumatic stress disorder
Tezcan, E., Atmaca, M., Kuloğlu, M., & Üstündağ, B. (2003) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-003-0413-x · Cited by 72 · see citing works
Zhang, X., Zhou, D. F., Su, J. M., & Zhang, P. Y. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200102000-00015 · Cited by 70 · see citing works
Glutathione peroxidase and CT scan abnormalities in schizophrenia
Buckman, T. D., Kling, A. S., Eiduson, S., Sutphin, M. S., & Steinberg, A. M. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90069-2 · Cited by 68 · see citing works
Chen, B., Wang, J. F., & Young, L. T. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00878-7 · Cited by 68 · see citing works
The possible pathophysiological role of plasma nitric oxide and adrenomedullin in schizophrenia
Zoroğlu, S. S., Herken, H., Yürekli, M., Uz, E., Tutkun, H., SAVAS, H. A., Bağcı, C., Özen, M. E., Cengiz, B., Çakmak, E. A., et al. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00014-6 · Cited by 67 · see citing works
Chen, J., Wersinger, C., & Sidhu, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303094200 · Cited by 67 · see citing works
Kovacic, P. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.01.031 · Cited by 67 · see citing works
Biomarkers of oxidative stress in schizophrenic and control subjects
Young, J. A., McKinney, S. B., Ross, B. M., Wahle, K. W. J., & Boyle, S. P. (2007) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.11.003 · Cited by 66 · see citing works
Sarandöl, A., Sarandöl, E., Eker, S. S., Karaagac, E. U., Hizli, B., Dirican, M., & Kırlı, S. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.04.012 · Cited by 64 · see citing works
de Vasconcellos, A. P. S., Nieto, F., Crema, L. M., Diehl, L. A., de Almeida, L. M., Prediger, M. E., da Rocha, E. R., & Dalmaz, C. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9139-2 · Cited by 63 · see citing works
Imbalanced free radicals and antioxidant defense systems in schizophrenia: A comparative study
Li, H.-C., Chen, Q., Ma, Y., & Zhou, J.-F. (2006) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.2006.b0981 · Cited by 62 · see citing works
The Effect of Risperidone Treatment on Superoxide Dismutase in Schizophrenia
Zhang, X., Zhou, D. F., Cao, L. Y., Zhang, P. Y., Wu, G. Y., & Shen, Y. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200304000-00004 · Cited by 61 · see citing works
Saadat, M., Mobayen, F., & Farrashbandi, H. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.03.024 · Cited by 60 · see citing works
Isoprostenes as indicators of oxidative stress in schizophrenia
Dietrich‐Muszalska, A., & Olas, B. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701361263 · Cited by 59 · see citing works
Hunsel, F. V., Wauters, A., Vandoolaeghe, E., Neels, H. M., Demedts, P., & Maes, M. H. J. (1996) · Psychiatry Research · doi:10.1016/s0165-1781(96)03010-7 · Cited by 58 · see citing works
Tenenbaum, S., Paull, J. C., Sparrow, E. P., Dodd, D., & GREEN, L. (2002) · Journal of Attention Disorders · doi:10.1177/108705470200600201 · Cited by 57 · see citing works
Oxidative stress in heroin administered mice and natural antioxidants protection
Pan, J., Zhang, Q., Zhang, Y., Ouyang, Z., Zheng, Q., & Zheng, R. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.12.025 · Cited by 57 · see citing works
Serum nitric oxide metabolite levels and the effect of antipsychotic therapy in schizophrenia
Taneli, F., Pırıldar, Ş., Akdeniz, F., Uyanık, B. S., & Arı, Z. (2004) · Archives of Medical Research · doi:10.1016/j.arcmed.2004.06.002 · Cited by 56 · see citing works
Glutathione as a cerebral substrate in depressive behavior
Pal, S. N., & Dandiya, P. C. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90191-0 · Cited by 54 · see citing works
The Role of Mitochondrial Dysfunction in Bipolar Disorder
Kato, T. (2006) · Drug News & Perspectives · doi:10.1358/dnp.2006.19.10.1068006 · Cited by 52 · see citing works
THE LACTIC ACID AND GLUTATHIONE CONTENT OF THE BLOOD OF SCHIZOPHRENIC PATIENTS 1
Looney, J. M., & Childs, H. M. (1934) · Journal of Clinical Investigation · doi:10.1172/jci100639 · Cited by 52 · see citing works
(2013) · Neurochemical Research · doi:10.1007/11064.1573-6903 · Cited by 52 · see citing works
Atmaca, M., Tezcan, E., Kuloğlu, M., Üstündağ, B., & KIRTAS, O. (2005) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2005.01432.x · Cited by 50 · see citing works
Shih, C., Chang, J.-H., Yang, S., Chou, T.-W., & Cheng, H.-H. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507781497 · Cited by 50 · see citing works
Is bipolar disorder a mitochondrial disease?
Young, L. T. (2007) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0715 · Cited by 50 · see citing works
Oxidative Status in Patients with Alcohol Dependence: A Clinical Study in Taiwan
Peng, F.-C., Tang, S. W., Huang, M.-C., Chen, C.-C., Kuo, T., & Yin, S. (2005) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390590967432 · Cited by 48 · see citing works
Hashimoto, T., Hashimoto, K., Matsuzawa, D., Shimizu, E., Sekine, Y., Inada, T., Ozaki, N., Iwata, N., Harano, M., Komiyama, T., et al. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30164 · Cited by 47 · see citing works
Miller, C. S. (1999) · Toxicology and Industrial Health · doi:10.1177/074823379901500302 · Cited by 46 · see citing works
Berk, M., Bodemer, W., Oudenhove, T. V., & Butkow, N. (1995) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470100304 · Cited by 44 · see citing works
Self-citationIs Cocaine Desire Reduced by N -Acetylcysteine?
LaRowe, S. D. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.164.7.1115 · Cited by 41 · see citing works
DNA damage and repair efficiency in lymphocytes from schizophrenic patients
Psimadas, D., Messini‐Nikolaki, N., Zafiropoulou, M., Fortos, A., Tsilimigaki, S., & Piperakis, S. M. (2003) · Cancer Letters · doi:10.1016/j.canlet.2003.09.022 · Cited by 39 · see citing works
Berns, S. M., Uzelac, S., González, C. M., & Jaeger, J. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00305.x · Cited by 38 · see citing works
Ascoli, G. A., Bertucci, C., & Salvadori, P. A. (1998) · Biomedical Chromatography · doi:10.1002/(sici)1099-0801(199809/10)12:5 · Cited by 37 · see citing works
Antioxidant Effect of Phenelzine on MPP+-Induced Cell Viability Loss in Differentiated PC12 Cells
Lee, C. S., Han, E. S., & Lee, W. B. (2003) · Neurochemical Research · doi:10.1023/a:1026119708124 · Cited by 32 · see citing works
Drieu, K., Vranckx, R., Benassayad, C., Haourigi, M., Hassid, J., Yoa, R. G., Rapin, J. R., & Nunez, E. A. (2000) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2000.0217 · Cited by 30 · see citing works
Hemmeter, U., Annen, B., Bischof, R., Brüderlin, U., Hatzinger, M., Rose, U., & Holsboer‐Trachsler, E. (2001) · Pharmacopsychiatry · doi:10.1055/s-2001-15182 · Cited by 28 · see citing works
Chan, A. S. L., Ng, L. W. C., Poon, L. S. W., Chan, W. W. Y., & Wong, Y. H. (2006) · APOPTOSIS · doi:10.1007/s10495-006-0524-8 · Cited by 28 · see citing works
Zhang, X. Y., Zhou, D. F., Cao, L. Y., & Wu, G. Y. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0476-2 · Cited by 25 · see citing works
Thiobarbituric acid reactive substances in the cerebrospinal fluid in schizophrenia
Skinner, A. O., Mahadik, S. P., & Garver, D. L. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.10.010 · Cited by 23 · see citing works
Zhou, D., Zhang, X., Su, J., Nan, Z., Cui, Y., Liu, J., Guan, Z., Zhang, P., & Shen, Y. (1999) · PubMed · Cited by 19 · see citing works
Lithium Blocks 45Ca2+ Uptake into Platelets in Bipolar Affective Disorder and Controls
Berk, M., Kirchmann, N. H., & Butkow, N. (1996) · Clinical Neuropharmacology · doi:10.1097/00002826-199619010-00002 · Cited by 17 · see citing works
Self-citationOpposite effects of antioxidants on anxiety in Wistar and OXYS rats
Kolosova, N. G., Trofimova, N. A., & Фурсова, А. Ж. (2006) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-006-0266-1 · Cited by 16 · see citing works
Petruzzelli, S., Tavanti, L. M., Pulerà, N., Fornai, E., Puntoni, R., Celi, A., & Giuntini, C. (2000) · Nicotine & Tobacco Research · doi:10.1080/713688155 · Cited by 16 · see citing works
HENNEMAN, D. H., & Altschule, M. D. (1951) · Journal of Applied Physiology · doi:10.1152/jappl.1951.3.7.411 · Cited by 15 · see citing works
Amanvermez, R., & Ağar, E. (2006) · Advances in Therapy · doi:10.1007/bf02850310 · Cited by 14 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638 · see citing works
Oxidative Stress and the Central Nervous System
Salim, S. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.237503 · Cited by 1,268 · see citing works
Berk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.001 · Cited by 1,178 · see citing works
Self-citationNrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease
Ngo, V., & Duennwald, M. L. (2022) · Antioxidants · doi:10.3390/antiox11122345 · Cited by 1,130 · see citing works
Clinical Relevance of Biomarkers of Oxidative Stress
Frijhoff, J., Winyard, P. G., Žarković, N., Davies, S. S., Stocker, R., Cheng, D., Knight, A. R., Taylor, E., Oettrich, J., Ruskovska, T., et al. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6317 · Cited by 918 · see citing works
Neuroinflammation and psychiatric illness
Najjar, S., Pearlman, D. M., Alper, K., Najjar, A., & Devinsky, O. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-43 · Cited by 733 · see citing works
Monoamine oxidase inactivation: from pathophysiology to therapeutics
Bortolato, M., Chen, K., & Shih, J. C. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.06.002 · Cited by 634 · see citing works
Gawryluk, J. W., Wang, J.-F., Andreazza, A. C., Shao, L., & Young, L. T. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000805 · Cited by 594 · see citing works
Oxidative Stress and Psychological Disorders
Salim, S. (2014) · Current Neuropharmacology · doi:10.2174/1570159x11666131120230309 · Cited by 557 · see citing works
Berk, M., Copolov, D., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., Judd, F., Katz, F., Katz, P., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.004 · Cited by 552 · see citing works
Self-citationRossignol, D. A., & Frye, R. E. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.165 · Cited by 545 · see citing works
Post-stroke depression: Mechanisms and pharmacological treatment
Villa, R. F., Ferrari, F., & Moretti, A. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.11.005 · Cited by 537 · see citing works
The neurobiology of depression and antidepressant action
Willner, P., Scheel-Krüger, J., & Belzung, C. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.12.007 · Cited by 519 · see citing works
Oxidative Stress and Anxiety: Relationship and Cellular Pathways
Bouayed, J., Rammal, H., & Soulimani, R. (2009) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.2.2.7944 · Cited by 517 · see citing works
McGuinness, A. J., Davis, J. A., Dawson, S. L., Loughman, A., Collier, F., O’Hely, M., Simpson, C. A., Green, J., Marx, W., Hair, C., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01456-3 · Cited by 502 · see citing works
Self-citationBerk, M., Copolov, D. L., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., & Bush, A. I. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.022 · Cited by 500 · see citing works
Self-citationDean, O., Giorlando, F., & Berk, M. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100057 · Cited by 494 · see citing works
Self-citationA Meta-analysis of oxidative stress markers in depression
Liu, T., Zhong, S., Liao, X., Chen, J., He, T., Lai, S., & Jia, Y. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138904 · Cited by 485 · see citing works
Oxidative stress, inflammation and treatment response in major depression
Lindqvist, D., Dhabhar, F. S., James, S. J., Hough, C. M., Jain, F. A., Bersani, F. S., Reus, V. I., Verhoeven, J. E., Epel, E. S., Mahan, L., et al. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.11.031 · Cited by 473 · see citing works
Oxidative stress in schizophrenia: An integrated approach
Bitanihirwe, B. K. Y., & Woo, T.-U. W. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.008 · Cited by 474 · see citing works
NOX Enzymes in the Central Nervous System: From Signaling to Disease
Sorce, S., & Krause, K. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2578 · Cited by 472 · see citing works
Potential Mechanisms of Action of Lithium in Bipolar Disorder
Malhi, G. S., Tanious, M., Das, P., Coulston, C. M., & Berk, M. (2013) · CNS Drugs · doi:10.1007/s40263-013-0039-0 · Cited by 464 · see citing works
Self-citationPun, V. C., Manjourides, J., & Suh, H. H. (2016) · Environmental Health Perspectives · doi:10.1289/ehp494 · Cited by 441 · see citing works
ROS and Brain Diseases: The Good, the Bad, and the Ugly
Popa-Wagner, A., Mitran, S., Sivanesan, S., Chang, E., & Buga, A.-M. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/963520 · Cited by 427 · see citing works
Wolkowitz, O. M., Mellon, S. H., Epel, E. S., Lin, J., Dhabhar, F. S., Su, Y., Reus, V. I., Rosser, R., Burke, H. M., Kupferman, E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017837 · Cited by 421 · see citing works
Free radicals, antioxidant defense systems, and schizophrenia
Wu, J. Q., Kosten, T. R., & Zhang, X. Y. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.02.015 · Cited by 420 · see citing works
<i>N</i> -acetylcysteine for antioxidant therapy: pharmacology and clinical utility
Dodd, S., Dean, O., Copolov, D. L., Malhi, G. S., & Berk, M. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14728220802517901 · Cited by 413 · see citing works
Self-citationCytokines in bipolar disorder vs. healthy control subjects: A systematic review and meta-analysis
Munkholm, K., Braüner, J. V., Kessing, L. V., & Vinberg, M. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.018 · Cited by 402 · see citing works
Air Pollution and Symptoms of Depression in Elderly Adults
Lim, Y., Kim, H., Kim, J. H., Bae, S., Park, H. Y., & Hong, Y. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1104100 · Cited by 402 · see citing works
Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness
Berk, M., Dean, O. M., Drexhage, H. A., McNeil, J. J., Moylan, S., O'Neil, A. E., Davey, C. G., Sanna, L., & Maes, M. H. J. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-74 · Cited by 392 · see citing works
Self-citationEmerging role of glutamate in the pathophysiology of major depressive disorder
Hashimoto, K. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.05.005 · Cited by 381 · see citing works
Power, M. C., Kioumourtzoglou, M., Hart, J. E., Okereke, O. I., Laden, F., & Weisskopf, M. G. (2015) · BMJ · doi:10.1136/bmj.h1111 · Cited by 380 · see citing works
A prospective study of diet quality and mental health in adolescents
Jacka, F. N., Kremer, P. J., Berk, M., de Silva-Sanigorski, A. M., Moodie, M., Leslie, E. R., Pasco, J. A., & Swinburn, B. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024805 · Cited by 374 · see citing works
Self-citationLopresti, A. L., Maker, G. L., Hood, S. D., & Drummond, P. D. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.09.017 · Cited by 371 · see citing works
Rossignol, D. A., & Frye, R. E. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00150 · Cited by 369 · see citing works
Oxidative stress in anxiety and comorbid disorders
Hovatta, I., Juhila, J., & Donner, J. (2010) · Neuroscience Research · doi:10.1016/j.neures.2010.08.007 · Cited by 365 · see citing works
Oxidative stress-related biomarkers in autism: Systematic review and meta-analyses
Frustaci, A., Neri, M., Cesario, A., Adams, J. B., Domenici, E., Bernardina, B. D., & Bonassi, S. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.03.011 · Cited by 370 · see citing works
Cai, W., Mueller, C., Li, Y.-J., Shen, W.-D., & Stewart, R. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.01.013 · Cited by 359 · see citing works
Oxidative stress in the skin: Impact and related protection
Chen, J., Liu, Y., Zhao, Z., & Qiu, J. (2021) · International Journal of Cosmetic Science · doi:10.1111/ics.12728 · Cited by 351 · see citing works
Salim, S., Chugh, G., & Asghar, M. (2012) · Advances in protein chemistry and structural biology · doi:10.1016/b978-0-12-398314-5.00001-5 · Cited by 315 · see citing works
Association of Microvascular Dysfunction With Late-Life Depression
van Agtmaal, M. J. M., Houben, A. J. H. M., Pouwer, F., Stehouwer, C. D. A., & Schram, M. T. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.0984 · Cited by 313 · see citing works
Jacka, F. N., Mykletun, A., Berk, M., Bjelland, I., & Tell, G. S. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318222831a · Cited by 304 · see citing works
Self-citationBiomarkers and clinical staging in psychiatry
McGorry, P. D., Keshavan, M. S., Goldstone, S. D., Amminger, G. P., Allott, K., Berk, M., Lavoie, S., Pantelis, C., Yung, A. R., Wood, S. J., et al. (2014) · World Psychiatry · doi:10.1002/wps.20144 · Cited by 305 · see citing works
Self-citationDepression gets old fast: do stress and depression accelerate cell aging?
Wolkowitz, O. M., Epel, E. S., Reus, V. I., & Mellon, S. H. (2010) · Depression and Anxiety · doi:10.1002/da.20686 · Cited by 298 · see citing works
Nutritional modulation of cognitive function and mental health
Parletta, N., Milte, C. M., & Meyer, B. J. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.01.002 · Cited by 304 · see citing works
Dietary recommendations for the prevention of depression
Opie, R. S., Itsiopoulos, C., Parletta, N., Sanchez-Villegas, A., Akbaraly, T. N., Ruusunen, A., & Jacka, F. N. (2017) · Nutritional Neuroscience · doi:10.1179/1476830515y.0000000043 · Cited by 287 · see citing works
Freudenmann, R. W., & Lepping, P. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00018-09 · Cited by 280 · see citing works
Superoxide Dismutase Administration: A Review of Proposed Human Uses
Rosa, A. C., Corsi, D., Cavi, N., Bruni, N., & Dosio, F. (2021) · Molecules · doi:10.3390/molecules26071844 · Cited by 286 · see citing works
Cytokines in bipolar disorder: A systematic review and meta-analysis
Munkholm, K., Vinberg, M., & Vedel Kessing, L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.06.010 · Cited by 256 · see citing works
Sleep deprivation, oxidative stress and inflammation
Atrooz, F., & Salim, S. (2019) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2019.03.001 · Cited by 258 · see citing works
Oxidative Stress in Schizophrenia
Grabnar, I., Vovk, T., Plesničar, B. K., & Boskovic, M. (2011) · Current Neuropharmacology · doi:10.2174/157015911795596595 · Cited by 250 · see citing works
Ambient air pollution and depression: A systematic review with meta-analysis up to 2019
Fan, S., Heinrich, J., Bloom, M. S., Zhao, T., Shi, T., Feng, W., Sun, Y., Shen, J., Yang, Z., Yang, B., et al. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.134721 · Cited by 256 · see citing works
Najjar, S., Pearlman, D. M., Devinsky, O., Najjar, A., & Zagzag, D. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-142 · Cited by 248 · see citing works
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Morris, G., & Berk, M. (2015) · BMC Medicine · doi:10.1186/s12916-015-0310-y · Cited by 245 · see citing works
Self-citationAgeing and neurodegenerative diseases
Hung, C.-W., Chen, Y., Hsieh, W.-L., Chiou, S., & Kao, C.-L. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.08.006 · Cited by 248 · see citing works
Kunz, M., Gama, C. S., Andreazza, A. C., Salvador, M. M., Ceresér, K. M., Gomes, F. A., Belmonte-de-Abreu, P. S., Berk, M., & Kapczinski, F. P. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.07.001 · Cited by 241 · see citing works
Self-citationJeste, D. V., Palmer, B. W., Rettew, D. C., & Boardman, S. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14nr09599 · Cited by 246 · see citing works
Karabatsiakis, A., Böck, C., Salinas-Manrique, J., Kolassa, S., Calzia, E., Dietrich, D. E., & Kolassa, I. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.44 · Cited by 239 · see citing works
INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES
Baru, P. C. R. (2014) · ADVANCED SCIENCES INDEX · Cited by 236 · see citing works
Behl, T., Rana, T., Alotaibi, G., Shamsuzzaman, M., Naqvi, M., Sehgal, A., Singh, S., Sharma, N., Almoshari, Y., Abdellatif, A. A. H., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112545 · Cited by 230 · see citing works
James, S. J., Rose, S., Melnyk, S., Jernigan, S., Blossom, S. J., Pavliv, O., & Gaylor, D. W. (2009) · The FASEB Journal · doi:10.1096/fj.08-128926 · Cited by 223 · see citing works
Najjar, S., Pahlajani, S. S., Sanctis, V. D., Stern, J. N. H., Najjar, A., & Chong, D. J. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00083 · Cited by 223 · see citing works
The Association Between Air Pollution and Onset of Depression Among Middle-Aged and Older Women
Kioumourtzoglou, M., Power, M. C., Hart, J. E., Okereke, O. I., Coull, B. A., Laden, F., & Weisskopf, M. G. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kww163 · Cited by 216 · see citing works
Moretti, M., Colla, A. R. D. S., Balen, G. O., Santos, D. B., Budni, J., Freitas, A. E., Farina, M., & Rodrigues, A. L. S. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.11.009 · Cited by 210 · see citing works
Evidence that oxidative stress is linked to anxiety-related behaviour in mice
Rammal, H., Bouayed, J., Younos, C., & Soulimani, R. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2008.06.005 · Cited by 204 · see citing works
Neuroprogression: pathways to progressive brain changes in bipolar disorder
Berk, M. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009498 · Cited by 203 · see citing works
Self-citationOxidative Stress and ADHD: A Meta-Analysis
Joseph, N., Zhang-James, Y., Perl, A., & Faraone, S. V. (2015) · Journal of Attention Disorders · doi:10.1177/1087054713510354 · Cited by 203 · see citing works
Liu, B., Xu, C., Wu, X., Liu, F., Du, Y., Sun, J., Tao, J., & Dong, J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.02.053 · Cited by 202 · see citing works
Filho, C. B., Jessé, C. R., Donato, F., Giacomeli, R., Fabbro, L. D., Antunes, M. D. S., de Gomes, M. G., Goes, A. T. R., Boeira, S. P., Prigol, M., et al. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.12.048 · Cited by 201 · see citing works
Peripheral Markers of Depression
Nobis, A., Zalewski, D., & Waszkiewicz, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123793 · Cited by 197 · see citing works
Rowland, T., Perry, B. I., Upthegrove, R., Barnes, N. M., Chatterjee, J., Gallacher, D., & Marwaha, S. (2018) · The British Journal of Psychiatry · doi:10.1192/bjp.2018.144 · Cited by 197 · see citing works
Weng, T.-T., Hao, J., Qing-wen, Q., Cao, H., Fu, J., Sun, Y., Huang, L., & Tao, F. (2011) · Public Health Nutrition · doi:10.1017/s1368980011003077 · Cited by 195 · see citing works
Using glutamate homeostasis as a target for treating addictive disorders
Reissner, K., & Kalivas, P. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833d41b2 · Cited by 185 · see citing works
Mazza, M. G., Lucchi, S., Rossetti, A., & Clerici, M. (2020) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2019.1583371 · Cited by 191 · see citing works
Potential Role of N-Acetylcysteine in the Management of Substance Use Disorders
McClure, E. A., Gipson, C. D., Malcolm, R. J., Kalivas, P. W., & Gray, K. M. (2014) · CNS Drugs · doi:10.1007/s40263-014-0142-x · Cited by 195 · see citing works
Magnetic field effects in biology from the perspective of the radical pair mechanism
Zadeh-Haghighi, H., & Simon, C. (2022) · Journal of The Royal Society Interface · doi:10.1098/rsif.2022.0325 · Cited by 197 · see citing works
Glutathione: a novel treatment target in psychiatry
Berk, M., Ng, F., Dean, O., Dodd, S., & Bush, A. I. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.05.001 · Cited by 183 · see citing works
Self-citationBerk, M., Dean, O., Cotton, S. M., Gama, C. S., Kapczinski, F., Fernandes, B. S., Kohlmann, K., Jeavons, S., Hewitt, K., Allwang, C., et al. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.06.005 · Cited by 181 · see citing works
Self-citationShungu, D. C., Weiduschat, N., Murrough, J. W., Mao, X., Pillemer, S., Dyke, J. P., Medow, M. S., Natelson, B. H., Stewart, J. M., & Mathew, S. J. (2012) · NMR in Biomedicine · doi:10.1002/nbm.2772 · Cited by 179 · see citing works
Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia
Jeste, D. V., Wolkowitz, O. M., & Palmer, B. W. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr026 · Cited by 176 · see citing works
Chen, C., Zhang, H., Cui, S., Han, B., Zhou, L., Zhang, N., Su, X., Niu, Y., Chen, W. L., Chen, R., et al. (2019) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2019.02.026 · Cited by 177 · see citing works
Glycogen Synthase Kinase-3 in the Etiology and Treatment of Mood Disorders
Jope, R. S. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00016 · Cited by 174 · see citing works
Raffa, M., Mechri, A., Othman, L. B., Fendri, C., Gaha, L., & Kerkeni, A. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.06.018 · Cited by 173 · see citing works
Bonaccio, M., Castelnuovo, A. F. D., Bonanni, A., Costanzo, S., Lucia, F. D., Pounis, G., Zito, F., Donati, M. B., de Gaetano, G., & Iacoviello, L. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003003 · Cited by 169 · see citing works
Möller, M., du Preez, J. L., Viljoen, F. P., Berk, M., Emsley, R. A., & Harvey, B. H. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.12.011 · Cited by 168 · see citing works
Self-citationRaffa, M., Atig, F., Mhalla, A., Kerkeni, A., & Mechri, A. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-124 · Cited by 168 · see citing works
Ghezzo, A., Visconti, P., Abruzzo, P. M., Bolotta, A., Ferreri, C., Gobbi, G., Malisardi, G., Manfredini, S., Marini, M., Nanetti, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066418 · Cited by 164 · see citing works
Enhanced Carbonyl Stress in a Subpopulation of Schizophrenia
Arai, M., Yuzawa, H., Nohara, I., Ohnishi, T., Obata, N., Iwayama, Y., Haga, S., Toyota, T., Ujike, H., Arai, M., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.62 · Cited by 164 · see citing works
A systematic review of metabolite biomarkers of schizophrenia
Davison, J., O’Gorman, A., Brennan, L., & Cotter, D. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.09.021 · Cited by 161 · see citing works
Oxidative imbalance in bipolar disorder subtypes: A comparative study
Yumru, M., SAVAS, H. A., Kalenderoğlu, A., Bulut, M., Çelık, H., & Erel, Ö. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.06.005 · Cited by 163 · see citing works
Du, J., Zhu, M. F., Bao, H., Bai, L., Dong, Y., Xiao, C., Zhang, G. Y., Henter, I. D., Rudorfer, M. V., & Vitiello, B. (2014) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2013.876960 · Cited by 164 · see citing works
Novel and Emerging Treatments for Autism Spectrum Disorders: A Systematic Review
Rossignol, D. A. (2009) · Annals of Clinical Psychiatry · doi:10.1177/104012370902100404 · Cited by 162 · see citing works
Meguid, N. A., Dardir, A. A., Raouf, E. R. A., & Hashish, A. F. (2010) · Biological Trace Element Research · doi:10.1007/s12011-010-8840-9 · Cited by 158 · see citing works
Farokhnia, M., Azarkolah, A., Adinehfar, F., Khodaie-Ardakani, M.-R., Hosseini, S.-M.-R., Yekehtaz, H., Tabrizi, M., Rezaei, F., Salehi, B., Sadeghi, S.-M.-H., et al. (2013) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000001 · Cited by 155 · see citing works
Microglial dysfunction connects depression and Alzheimer’s disease
Santos, L. E., Beckman, D., & Ferreira, S. T. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.11.011 · Cited by 119 · see citing works
Lopresti, A. L., Hood, S. D., & Drummond, P. D. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112458732 · Cited by 151 · see citing works
The role of glutathione redox imbalance in autism spectrum disorder: A review
Bjørklund, G., Tinkov, A. A., Hosnedlová, B., Kizek, R., Ajsuvakova, O. P., Chirumbolo, S., Геннадиевна, С. М., Peana, M., Dadar, M., El-Ansary, A. K., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.07.017 · Cited by 150 · see citing works
Chatzi, L., Melaki, V., Sarri, K. O., Apostolaki, I., Roumeliotaki, T., Georgiou, V., Vassilaki, M. E., Koutis, A. D., Bitsios, P., & Kogevinas, M. (2011) · Public Health Nutrition · doi:10.1017/s1368980010003629 · Cited by 151 · see citing works
Versace, A., Andreazza, A. C., Young, L. T., Fournier, J. C. J., Almeida, J., Stiffler, R. S., Lockovich, J., Aslam, H. A., Pollock, M., Park, H., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.188 · Cited by 144 · see citing works
Oxidative stress markers in affective disorders
Siwek, M., Sowa-Kućma, M., Dudek, D., Styczeń, K., Szewczyk, B., Kotarska, K., Misztak, P., Pilc, A., Wolak, M., & Nowak, G. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71517-2 · Cited by 142 · see citing works
- Authors
- Ng, F., Berk, M., Dean, O., & Bush, A. I.
- Affiliations
- Barwon Health (AU)
- Mental Health Research Institute (AU)
- Venue
- The International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-01-21
- Volume
- 11
- Issue
- 06
- Pages
- 851-76
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W1986211748
- Cited by
- 1,069
- References
- 203
- Citations by year
- 2026: 23 · 2025: 52 · 2024: 49 · 2023: 60 · 2022: 52 · 2021: 81 · 2020: 73 · 2019: 69 · 2018: 74 · 2017: 42 · 2016: 84 · 2015: 71 · 2014: 74 · 2013: 68 · 2012: 50
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The International Journal of Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Deakin Research Online (Deakin University) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Biochemistry › Antioxidant Activity and Oxidative Stress
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- oxidative stress, mental illness, schizophrenia, bipolar disorder, depression, anxiety disorders, cocaine dependence, autism spectrum disorder, attention deficit hyperactivity disorder, antioxidants, N-acetylcysteine, oxidative stress biomarkers, psychopharmacology, common pathogenic mechanisms
- MeSH terms
- Antioxidants, Mental Disorders, Humans, Databases, Bibliographic, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review